- Home
- UONEK vs ENLV Comparison
UONEK vs ENLV Comparison
Compare UONEK & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UONEK
- ENLV
- Stock Information
- Founded
- UONEK 1980
- ENLV 2005
- Country
- UONEK United States
- ENLV Israel
- Employees
- UONEK N/A
- ENLV N/A
- Industry
- UONEK Broadcasting
- ENLV Biotechnology: Pharmaceutical Preparations
- Sector
- UONEK Consumer Discretionary
- ENLV Health Care
- Exchange
- UONEK Nasdaq
- ENLV Nasdaq
- Market Cap
- UONEK 28.1M
- ENLV 25.5M
- IPO Year
- UONEK N/A
- ENLV 1995
- Fundamental
- Price
- UONEK $0.71
- ENLV $1.13
- Analyst Decision
- UONEK
- ENLV Strong Buy
- Analyst Count
- UONEK 0
- ENLV 2
- Target Price
- UONEK N/A
- ENLV $10.00
- AVG Volume (30 Days)
- UONEK 22.4K
- ENLV 175.2K
- Earning Date
- UONEK 11-06-2025
- ENLV 08-29-2025
- Dividend Yield
- UONEK N/A
- ENLV N/A
- EPS Growth
- UONEK N/A
- ENLV N/A
- EPS
- UONEK N/A
- ENLV N/A
- Revenue
- UONEK $411,386,000.00
- ENLV N/A
- Revenue This Year
- UONEK N/A
- ENLV N/A
- Revenue Next Year
- UONEK N/A
- ENLV N/A
- P/E Ratio
- UONEK N/A
- ENLV N/A
- Revenue Growth
- UONEK N/A
- ENLV N/A
- 52 Week Low
- UONEK $0.44
- ENLV $0.81
- 52 Week High
- UONEK $1.40
- ENLV $2.10
- Technical
- Relative Strength Index (RSI)
- UONEK 45.55
- ENLV 57.20
- Support Level
- UONEK $0.68
- ENLV $1.01
- Resistance Level
- UONEK $0.73
- ENLV $1.08
- Average True Range (ATR)
- UONEK 0.06
- ENLV 0.04
- MACD
- UONEK -0.01
- ENLV 0.02
- Stochastic Oscillator
- UONEK 24.99
- ENLV 87.86
About UONEK Urban One Inc. Class D
Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.